TCOYD Home
image

A CME Dinner Program Series

Practical Strategies for Advancing Insulin Therapy:

From Timely Initiation and Appropriate Titration of Basal Insulin to Addressing Postprandial Glucose Control

The Med-IQ/Taking Control Of Your Diabetes New and Emerging Insulin Continuing Medical Education evening series will be offered in ten different cities during the 2016 year.

The importance of postprandial glucose control has long been overlooked. In type 2 diabetes, there is an unmet need for ultra fast-acting insulins to more effectively and efficiently control post-meal glucose values while simultaneously limiting delayed hypoglycemia and weight gain. In addition to controlling postprandial glucose values, there is a need to treat incidental hyperglycemia between meals when appropriate, which points to the demand for a rapid-on, rapid-off insulin. Identification of postprandial elevation is an important first step, followed by the design of an individualized insulin regimen to address basal and prandial insulin needs, which is crucial for overall safe and effective glucose control.

There is a marked behavioral resistance to advancing insulin therapy in type 2 diabetes for not only patients, but also HCPs. In particular, HCPs avoid intensifying mealtime insulin for a host of reasons: time constraints, or the perception of time constraints, lack of comfort and confidence regarding how to intensify and titrate mealtime therapy, fear of complications due to advancing therapy, and deficient knowledge and training regarding how to address these concerns. As mentioned above, patients are often resistant to advancing insulin therapy primarily due to common misconceptions, including: fear and concern about additional injections, the belief that more insulin and/or more injections means that their health is worsening, concern that additional insulin will contribute to poorer health outcomes, feelings of being overwhelmed by the complexity that mealtime therapy will presumably introduce, the possibility of social stigma, and worries about weight gain and hypoglycemia.

2016 Advancing Insulin Therapy Dinner Series

  • July 13, 2016
     
    Phoenix, AZ - Arizona Grand Resort
  • July 14, 2016
     
    San Diego, CA - La Jolla Hyatt
  • August 3, 2016
     
    Atlanta, GA - The Ritz-Carlton Atlanta
  • August 10, 2016
     
    Portland, OR - The Benson
  • August 17, 2016
     
    Orlando, FL - Hyatt Regency Grand Cypress
  • October 5, 2016
     
    Denver, CO - Grand Hyatt Denver
  • October 26, 2016
     
    Las Vegas, NV - The Cosmopolitan
  • November 2, 2016
     
    Kansas City, MO - Crowne Plaza Kansas City Downtown
  • November 3, 2016
     
    Salt Lake City, UT - Grand America
  • December 1, 2016
     
    Santa Clara, CA - Hilton Santa Clara

Acknowledgment of Commercial Support

  • This activity is supported by an educational grant from Sanofi US.
Message
OK